Key result
AI-guided CCTA improves CVD diagnostic accuracy and prognostic value by automating atherosclerosis quantification.
Why the study?
Recent advancements in artificial intelligence applied to CCTA may refine personalized care by enhancing atherosclerosis visualization, improving cardiovascular risk stratification, and guiding treatment.
AI-guided CCTA analysis provides automated and scalable plaque quantification, enhancing personalized cardiovascular risk stratification and treatment guidance.
AI-enhanced imaging may aid atherosclerosis detection and prognosis; hypothesis-generating and requires prospective validation before practice change.
PURPOSE OF REVIEW: Recent advancements in artificial intelligence (AI) applied to coronary computed tomography angiography (CCTA) may refine personalized care by enhancing visualization of atherosclerosis, improving cardiovascular risk stratification and treatment guidance. The present review focuses on AI-guided innovations in CCTA analysis to evaluate atherosclerotic cardiovascular disease (ASCVD), its prognostic utility, and future directions. RECENT FINDINGS: AI-guided CCTA-analysis facilitates automated, reproducible, and scalable quantification of atherosclerosis. A growing body of evidence supports the diagnostic performance of AI-guided plaque quantification on CCTA. These advances support a shift toward more objective and individualized patient care beyond traditional, population-based approaches. As CCTA continues to evolve as an established, first-line diagnostic test to assess ASCVD, a growing body of evidence also supports the diagnostic accuracy and prognostic value of AI-guided CCTA.
No takes yet. Share an insight, caveat, or question.
Cramer et al. (2026) conducted a review in Atherosclerotic cardiovascular disease (ASCVD). Artificial intelligence-guided coronary computed tomography angiography (CCTA) was evaluated. AI-guided coronary computed tomography angiography facilitates automated quantification of atherosclerosis, supporting improved diagnostic accuracy and prognostic value for cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: